Siren Biotechnology

Siren Biotechnology We are revolutionizing the future of cancer treatment with universal AAV immuno-gene therapy! Follow us: https://www.sirenbiotechnology.com

🎉 Congratulations to Christine Xie on wrapping up a successful summer internship at Siren Biotechnology! Christine, a st...
09/03/2026

🎉 Congratulations to Christine Xie on wrapping up a successful summer internship at Siren Biotechnology! Christine, a student at , spent the summer generating business development materials that guide Siren's strategic positioning as we advance our Universal AAV Immuno-Gene Therapy for Cancer. Her work will continue to serve the team long after her last day. Please join us in congratulating Christine and wishing her all the best as she heads back to Stanford this fall!

September is , and Siren is thinking of every child and family facing a cancer diagnosis. Every step we take to advanc...
09/01/2026

September is , and Siren is thinking of every child and family facing a cancer diagnosis. Every step we take to advance Universal AAV for is for the patients and families who need better options. Let's sound the alarm against !

📣 BIG news to close out the week! Siren Biotechnology has been awarded an $8M non-dilutive CLIN2 grant from to support...
06/26/2026

📣 BIG news to close out the week! Siren Biotechnology has been awarded an $8M non-dilutive CLIN2 grant from to support our Phase 1/2 clinical trial of SRN-101 in adult recurrent high-grade glioma! We're incredibly grateful to CIRM and the vision and support of all Californians. Let's sound the alarm against !

Siren Biotechnology is headed to next week! Find us at the events below to learn more about our path to the clinic wit...
05/05/2026

Siren Biotechnology is headed to next week! Find us at the events below to learn more about our path to the clinic with , our lead AAV immuno for . See you in Boston!

BIG moment for ! 🚨We’re thrilled to share that our first peer-reviewed manuscript is now published in Molecular Therap...
04/27/2026

BIG moment for ! 🚨

We’re thrilled to share that our first peer-reviewed manuscript is now published in Molecular Therapy Oncology - and we’re heading to 2026 with even more data to share!

This publication showcases the foundation of our Universal AAV Immuno-Gene Therapy platform, including groundbreaking preclinical data in high-grade glioma, one of the toughest cancers with the greatest unmet need.

What we’re seeing:

🧬 Durable localized cytokine expression

🔥 Robust anti-tumor activity across multiple orthogonal human model systems

📉 Profound tumor regression + significantly increased survival

🎯 Tumor-localized immune activation

Huge thanks to our team and collaborators for supporting this work!

👉 Read the full press release here: https://sirenbiotechnology.com/siren-biotechnology-publishes-foundational-aav-immuno-gene-therapy-data-and-announces-presentations-at-asgct-2026/

👉 Access the open access manuscript here: [https://www.cell.com/molecular-therapy-family/oncology/fulltext/S2950-3299(26)00059-7](https://www.cell.com/molecular-therapy-family/oncology/fulltext/S2950-3299(26)00059-7)

Want more, like our IND large animal data? Come find us at !

Join Siren Biotechnology's CEO and other industry leaders at the National Organization for Rare Disorders, Inc. (NORD) ...
04/08/2026

Join Siren Biotechnology's CEO and other industry leaders at the National Organization for Rare Disorders, Inc. (NORD) Scientific Symposium next week! We’ll be sharing ways to bring community members in as company stakeholders through community fundraising. Register here: https://nordscience.org/

Address

San Francisco, CA

Website

Alerts

Be the first to know and let us send you an email when Siren Biotechnology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category